Quantcast

Latest Drug safety Stories

2014-02-28 08:24:20

ALBANY, New York, February 28, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global pharmacovigilance market was valued at USD 2,147.3 million...

2014-02-25 23:01:34

More than 30 program offerings will delve into the safety of medicines and clinical practices. Horsham, PA (PRWEB) February 25, 2014 The Food and Drug Administration (FDA) and European Medicines Agency (EMA) will discuss common objectives and challenges in pharmacovigilance and clinical safety at DIA’s Annual Meeting from June 15 to 19 in San Diego. The June 17 session, “FDA-EMA Collaboration in Pharmacovigilance: Common Objectives and Common Challenges,” will focus on joint efforts...

2014-02-24 23:25:45

Xtalks presents an exciting live webinar on Thursday, March 13, 2014 at 10:00am EDT (14:00 GMT). Join keynote speaker Michal Borawski, International Pharmacovigilance Officer for the Asia-Pacific Region Affairs at Sanofi Pasteur for a one-hour discussion on Pharmacovigilance in APAC. Toronto, Canada (PRWEB) February 24, 2014 Increases in drug safety concerns in recent years due to some high profile drug withdrawals have led to a reevaluation of the pharmacovigilance process by...

2014-02-19 16:23:46

In the news release, CHPA Responds to Economic Impact Study on Prescription Requirement in WV, issued Feb. 19, 2014 by Consumer Healthcare Products Association over PR Newswire, we are advised by the company that the subheadline should read "West Liberty University Professor Predicts a Total Cost of $149.4 Million for the State" rather than "$247.6 Million" as originally issued inadvertently. The complete, updated release follows: CHPA Responds to Economic Impact Study on Prescription...

2014-02-19 12:29:05

West Liberty University Professor Predicts a Total Cost of $247.6 Million for the State WASHINGTON, Feb. 19, 2014 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement regarding a new economic impact study conducted by Dr. Serkan Catma of West Liberty University. The study, which was supported by a grant from CHPA, examined the potential costs associated with a proposed prescription requirement for cold and allergy medicines...

2014-02-18 16:26:46

WASHINGTON, Feb. 18, 2014 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement after the West Virginia State Senate passed Senate Bill 6--legislation that would require all citizens to obtain a doctor's prescription before buying safe and effective cold and allergy medicines containing pseudoephedrine (PSE)--medicines like Advil Cold & Sinus, Claritin-D, Mucinex D and Sudafed. The bill now heads to the House of Delegates for...

2014-02-05 23:28:52

National Law Firm Settles Flu Vaccine Injury Petition under the National Vaccine Injury Compensation Program. Many are not aware of Compensation Program and the short, strict deadlines that must be met in order to qualify. Wellesley Hills, MA (PRWEB) February 05, 2014 Gold law Firm, LLC recently obtained a large settlement for a 92-year old woman who had a severe reaction to the Influenza Vaccine resulting in Guillain-Barre' Syndrom (“GBS”) . The case, filed in the Court of...

2014-02-03 08:28:34

RYE, N.Y., Feb. 3, 2014 /PRNewswire/ -- Curemark, a drug research and development company focused on neurological disorders, announced that the company has been awarded 6 new patents for its enzyme delivery system. The new patents, issued in Europe, Australia and Central America, extend to 2030 and can be utilized for multiple enzyme products including CM-AT, Curemark's proprietary autism drug. "We are thrilled to receive these patents," stated Dr. Joan Fallon, Curemark founder and...

2014-01-24 08:23:52

DUBLIN, Jan. 24, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin® Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013. (Logo:...

2014-01-15 08:29:16

NEW DELHI, January 15, 2014 /PRNewswire/ -- - Cold and Cough remedies has conventionally remained the leading segment of the industry with a value share of 24.9% of the total sales as of 2012 - The vitamins and mineral supplements sales value have increased predominantly over the years from USD 873.9 million in 2006 to USD 1,091.9 million in 2012 - Slovakia has emerged as the fastest growing market for OTC drugs in the region...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related